<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font25 { font-size : 25; } .font26 { font-size : 26; } .font27 { font-size : 27; } .font29 { font-size : 29; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">coronavirus </span>
   <span class="font29">inhibitors </span>
   <span class="font27">respiratory </span>
   <span class="font26">[]. </span>
   <span class="font25">MERS-CoV </span>
   <span class="font23">inhibitor </span>
   <span class="font22">SARS-CoV </span>
   <span class="font22">syndrome </span>
   <span class="font22">human </span>
   <span class="font21">replication </span>
   <span class="font20">viral </span>
   <span class="font20">antiviral </span>
   <span class="font20">protease </span>
   <span class="font19">virus </span>
   <span class="font18">activity </span>
   <span class="font18">SARS </span>
   <span class="font18">infection </span>
   <span class="font18">inhibit </span>
   <span class="font17">Med. </span>
   <span class="font17">acute </span>
   <span class="font17">Fig. </span>
   <span class="font17">severe </span>
   <span class="font17">entry </span>
   <span class="font16">East </span>
   <span class="font16">coronaviruses </span>
   <span class="font16">CLpro </span>
   <span class="font16">reported </span>
   <span class="font16">treatment </span>
   <span class="font16">Chem. </span>
   <span class="font16">Middle </span>
   <span class="font15">protein </span>
   <span class="font15">synthesis </span>
   <span class="font15">broad-spectrum </span>
   <span class="font15">potent </span>
   <span class="font15">CoVs </span>
   <span class="font15">Virol. </span>
   <span class="font15">host </span>
   <span class="font15">novel </span>
   <span class="font15">{border-style </span>
   <span class="font15">PLpro </span>
   <span class="font15">RNA </span>
   <span class="font15">showed </span>
   <span class="font15">target </span>
   <span class="font14">(.) </span>
   <span class="font14">cell </span>
   <span class="font14">drugs </span>
   <span class="font14">px;} </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">(), </span>
   <span class="font14">Infect. </span>
   <span class="font14">acid </span>
   <span class="font14">inhibited </span>
   <span class="font14">used </span>
   <span class="font14">agents </span>
   <span class="font14">interferon </span>
   <span class="font14">potential </span>
   <span class="font13">compound </span>
   <span class="font13">patients </span>
   <span class="font13">Dis. </span>
   <span class="font13">Figure </span>
   <span class="font13">cells </span>
   <span class="font13">compounds </span>
   <span class="font13">including </span>
   <span class="font13">targeting </span>
   <span class="font13">Res. </span>
   <span class="font13">development </span>
   <span class="font13">identified </span>
   <span class="font13">important </span>
   <span class="font13">proteins </span>
   <span class="font13">(Fig. </span>
   <span class="font13">CoV </span>
   <span class="font13">Table </span>
   <span class="font13">anti-viral </span>
   <span class="font13">clinical </span>
   <span class="font13">drug </span>
   <span class="font13">fusion </span>
   <span class="font13">infections </span>
   <span class="font13">inhibition </span>
   <span class="font13">new </span>
   <span class="font13">vitro </span>
   <span class="font12">HCoV-OC </span>
   <span class="font12">[], </span>
   <span class="font12">activities </span>
   <span class="font12">combination </span>
   <span class="font12">papain-like </span>
   <span class="font12">receptor </span>
   <span class="font12">ribavirin </span>
   <span class="font12">However, </span>
   <span class="font12">early </span>
   <span class="font12">effect </span>
   <span class="font12">inhibits </span>
   <span class="font12">proteases </span>
   <span class="font12">response </span>
   <span class="font12">screening </span>
   <span class="font12">Agents </span>
   <span class="font12">HCoV-E </span>
   <span class="font12">MERS </span>
   <span class="font12">Neurotransmitter </span>
   <span class="font12">agent </span>
   <span class="font12">anti-CoV </span>
   <span class="font12">discovery </span>
   <span class="font12">effective </span>
   <span class="font12">inhibitory </span>
   <span class="font12">mycophenolic </span>
   <span class="font12">range </span>
   <span class="font12">signaling </span>
   <span class="font12">using </span>
   <span class="font12">values </span>
   <span class="font12">viruses </span>
   <span class="font12">(&amp;gt;) </span>
   <span class="font12">Chemother. </span>
   <span class="font12">MERS-CoVs </span>
   <span class="font12">Sci. </span>
   <span class="font12">active </span>
   <span class="font12">biological </span>
   <span class="font12">evaluation </span>
   <span class="font12">inhibitors, </span>
   <span class="font12">px; </span>
   <span class="font12">site </span>
   <span class="font12">spike </span>
   <span class="font12">structure </span>
   <span class="font12">study </span>
   <span class="font12">{font-family </span>
   <span class="font11">SARS- </span>
   <span class="font11">and/or </span>
   <span class="font11">based </span>
   <span class="font11">clathrin-mediated </span>
   <span class="font11">cysteine </span>
   <span class="font11">different </span>
   <span class="font11">enzyme </span>
   <span class="font11">font-size </span>
   <span class="font11">genomic </span>
   <span class="font11">high </span>
   <span class="font11">involved </span>
   <span class="font11">low </span>
   <span class="font11">pathway </span>
   <span class="font11">research </span>
   <span class="font11">series </span>
   <span class="font11">shown </span>
   <span class="font11">studies </span>
   <span class="font11">therapeutic </span>
   <span class="font11">therapy </span>
   <span class="font11">various </span>
   <span class="font11">μM, </span>
   <span class="font11">μM. </span>
   <span class="font11">(nsp), </span>
   <span class="font11">Acad. </span>
   <span class="font11">Compound </span>
   <span class="font11">MERS-CoV, </span>
   <span class="font11">Microbiol. </span>
   <span class="font11">acts </span>
   <span class="font11">antivirals </span>
   <span class="font11">binding </span>
   <span class="font11">block </span>
   <span class="font11">control </span>
   <span class="font11">derivatives </span>
   <span class="font11">discovered </span>
   <span class="font11">double; </span>
   <span class="font11">endocytosis </span>
   <span class="font11">example, </span>
   <span class="font11">hydrochloride </span>
   <span class="font11">main </span>
   <span class="font11">micromolar </span>
   <span class="font11">moderate </span>
   <span class="font11">molecules </span>
   <span class="font11">monophosphate </span>
   <span class="font11">mutant </span>
   <span class="font11">scaffold </span>
   <span class="font11">small </span>
   <span class="font11">specific </span>
   <span class="font11">virus, </span>
   <span class="font11">DNA </span>
   <span class="font11">Ebola </span>
   <span class="font11">Elsevier </span>
   <span class="font11">HCoV-NL </span>
   <span class="font11">Lett. </span>
   <span class="font11">MERS- </span>
   <span class="font11">Natl. </span>
   <span class="font11">Nipah </span>
   <span class="font11">SARS-CoV, </span>
   <span class="font11">SARS-and </span>
   <span class="font11">SARS-coronavirus </span>
   <span class="font11">analogs </span>
   <span class="font11">approach </span>
   <span class="font11">approved </span>
   <span class="font11">associated </span>
   <span class="font11">available </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">broad </span>
   <span class="font11">cellular </span>
   <span class="font11">coronaviruses, </span>
   <span class="font11">corticosteroid </span>
   <span class="font11">decahydroisoquinoline </span>
   <span class="font11">developing </span>
   <span class="font11">did </span>
   <span class="font11">dipeptidyl </span>
   <span class="font11">displayed </span>
   <span class="font11">emerging </span>
   <span class="font11">enzymes </span>
   <span class="font11">evaluated </span>
   <span class="font11">hepatitis </span>
   <span class="font11">identification </span>
   <span class="font11">infections. </span>
   <span class="font11">influenza </span>
   <span class="font11">interactions </span>
   <span class="font11">library </span>
   <span class="font11">life </span>
   <span class="font11">mechanism </span>
   <span class="font11">membrane </span>
   <span class="font11">natural </span>
   <span class="font11">nucleic </span>
   <span class="font11">outcome </span>
   <span class="font11">peptide </span>
   <span class="font11">replicase </span>
   <span class="font11">respectively. </span>
   <span class="font11">resulting </span>
   <span class="font11">serine </span>
   <span class="font11">sialic </span>
   <span class="font11">significant </span>
   <span class="font11">silvestrol </span>
   <span class="font11">solid; </span>
   <span class="font11">structural </span>
   <span class="font11">suggest </span>
   <span class="font11">synthesis, </span>
   <span class="font11">type </span>
   <span class="font11">viruses, </span>
   <span class="font11">vivo </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(CC) </span>
   <span class="font11">(ii) </span>
   <span class="font11">ACE </span>
   <span class="font11">Antimicrob. </span>
   <span class="font11">Biol. </span>
   <span class="font11">C-like </span>
   <span class="font11">COVID- </span>
   <span class="font11">CoVs. </span>
   <span class="font11">Coimbatore, </span>
   <span class="font11">Coronaviruses </span>
   <span class="font11">HCV </span>
   <span class="font11">Professor </span>
   <span class="font11">Recently, </span>
   <span class="font11">Research </span>
   <span class="font11">Structure </span>
   <span class="font11">University </span>
   <span class="font11">University, </span>
   <span class="font11">X-ray </span>
   <span class="font11">[alt-text] </span>
   <span class="font11">action, </span>
   <span class="font11">addition </span>
   <span class="font11">analog </span>
   <span class="font11">animal </span>
   <span class="font11">anti-MERS-CoV </span>
   <span class="font11">assay </span>
   <span class="font11">bold </span>
   <span class="font11">cathepsin </span>
   <span class="font11">cause </span>
   <span class="font11">cells. </span>
   <span class="font11">centre </span>
   <span class="font11">chronic </span>
   <span class="font11">class </span>
   <span class="font11">coronaviral </span>
   <span class="font11">coronavirus: </span>
   <span class="font11">courier; </span>
   <span class="font11">cycle </span>
   <span class="font11">derivative </span>
   <span class="font11">design </span>
   <span class="font11">design, </span>
   <span class="font11">designed </span>
   <span class="font11">developed </span>
   <span class="font11">domain </span>
   <span class="font11">dual </span>
   <span class="font11">effects </span>
   <span class="font11">efficacy </span>
   <span class="font11">em; </span>
   <span class="font11">enveloped </span>
   <span class="font11">essential </span>
   <span class="font11">excellent </span>
   <span class="font11">functional </span>
   <span class="font11">genome </span>
   <span class="font11">highly </span>
   <span class="font11">humans </span>
   <span class="font11">immune </span>
   <span class="font11">infection. </span>
   <span class="font11">inhibitor, </span>
   <span class="font11">inhibitorsBioorg. </span>
   <span class="font11">interferons </span>
   <span class="font11">isolated </span>
   <span class="font11">kinase </span>
   <span class="font11">known </span>
   <span class="font11">major </span>
   <span class="font11">management </span>
   <span class="font11">molecule </span>
   <span class="font11">non-structural </span>
   <span class="font11">nsp </span>
   <span class="font11">numerous </span>
   <span class="font11">observed </span>
   <span class="font11">outbreak </span>
   <span class="font11">oxygen </span>
   <span class="font11">peptidomimetic </span>
   <span class="font11">primary </span>
   <span class="font11">produce </span>
   <span class="font11">promising </span>
   <span class="font11">properties </span>
   <span class="font11">protein, </span>
   <span class="font11">pt;} </span>
   <span class="font11">received </span>
   <span class="font11">recent </span>
   <span class="font11">resource </span>
   <span class="font11">retrospective </span>
   <span class="font11">ritonavir </span>
   <span class="font11">role </span>
   <span class="font11">selective </span>
   <span class="font11">sequence </span>
   <span class="font11">small-molecule </span>
   <span class="font11">species </span>
   <span class="font11">stages </span>
   <span class="font11">suggested </span>
   <span class="font11">suggesting </span>
   <span class="font11">therapeutics </span>
   <span class="font11">treat </span>
   <span class="font11">treated </span>
   <span class="font11">trials </span>
   <span class="font11">use </span>
   <span class="font11">working </span>
  </p>
 </body>
</html>
